By Abigail Townsend
Date: Tuesday 24 Feb 2026
(Sharecast News) - Shares in Convatec Group sparked in early trading on Monday, after the medical products business boosted medium-term guidance following a jump in annual sales and earnings.
| Holding(s) in Company | 19-Dec-2025 | ShareCast |
| Convatec slumps on Novo Holdings exit | 18-Nov-2025 | ShareCast |
| Convatec on track amid broad-based revenue growth | 13-Nov-2025 | ShareCast |
| Convatec finalises leadership reshuffle | 06-Nov-2025 | ShareCast |
| Convatec CEO Karim Bitar passes away | 27-Oct-2025 | ShareCast |
| Convatec FY25 Results | 24-Feb-2026 | 07:00 | RNS |
| Holding(s) in Company | 06-Feb-2026 | 11:00 | RNS |
| Total Voting Rights | 02-Jan-2026 | 11:00 | RNS |
| Holding(s) in Company | 19-Dec-2025 | 12:00 | RNS |
| Holding(s) in Company | 19-Dec-2025 | 12:00 | RNS |
| Convatec raises outlook with new specialist medi... | 25-Feb-2026 | Times |
No recent information was found.
No recent information was found.
| Currency | UK Pounds |
| Share Price | 243.80p |
| Change Today | -4.80p |
| % Change | -1.93 % |
| 52 Week High | 295.40p |
| 52 Week Low | 220.00p |
| Volume | 8,964,511 |
| Shares Issued | 1,954.85m |
| Market Cap | £4,765.93m |
| Beta | 0.00 |
| RiskGrade | 96 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 8 |
| Buy | 7 |
| Neutral | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 17 |

| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 16-Apr-26 | 21-Aug-25 |
| Paid | 28-May-26 | 01-Oct-25 |
| Amount | 5.37¢ | 1.88¢ |
| Time | Volume / Share Price |
| 16:46 | 4,034 @ 244.99p |
| 16:44 | 1,000 @ 246.80p |
| 16:39 | 8,283 @ 243.80p |
| 16:39 | 25,304 @ 243.80p |
| 16:38 | 1,452 @ 243.80p |
| Chair | John McAdam |
| CEO | Jonny Mason |
| CFO | Fiona Ryder |
You are here: research